---
figid: PMC7162481__pone.0230248.g004
figtitle: Genome-wide DNA methylation signatures to predict pathologic complete response
  from combined neoadjuvant chemotherapy with bevacizumab in breast cancer
organisms:
- Homo sapiens
pmcid: PMC7162481
filename: pone.0230248.g004.jpg
figlink: pmc/articles/PMC7162481/figure/pone.0230248.g004/
number: F4
caption: . Ingenuity pathway analysis of DM CpGs after 4 cycles of NCT treatment among
  (a) responders and (b) non-responders.
papertitle: Genome-wide DNA methylation signatures to predict pathologic complete
  response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer.
reftext: Ping-Ching Hsu, et al. PLoS One. 2020;15(4):e0230248.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7947134
figid_alias: PMC7162481__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7162481__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7162481__pone.0230248.g004.html
  '@type': Dataset
  description: . Ingenuity pathway analysis of DM CpGs after 4 cycles of NCT treatment
    among (a) responders and (b) non-responders.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIA2
  - CCNDBP1
  - CP
  - EMSY
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - HOXB13
  - FLOT1
  - DNMT3B
  - ALK
  - KDELR2
  - BCL2
  - GAS2L3
  - NAF1
  - TNIP1
  - CISD2
  - MDM2
  - SDCBP
  - SMARCB1
  - CDK1
  - XPC
  - ITPR1
  - RNF111
  - JAK1
  - LYN
  - FOXA1
  - IL6ST
  - CD58
  - HNF1B
  - MECOM
  - MAML3
  - KRT19
  - RBM38
  - TWIST2
  - CCND1
  - SKI
  - HADHA
  - KRT18
  - CDKN1A
  - CDPF1
  - ZEB2
  - HADHB
  - ALOX5
  - FPR2
  - SP1
  - PSG1
  - DAND5
  - BCL2L2
  - IL2
  - MAPK1
  - BHLHE40
  - ADRA1B
  - NFATC1
  - NR3C1
  - GRIN1
  - GPRIN1
  - RAD21
  - RPS6KA2
  - CD40LG
  - FUT3
  - GPR65
  - SCNN1A
  - STK39
  - TFAPZA
  - O
  - cancer
---
